1. Home
  2. ENTA vs BOOM Comparison

ENTA vs BOOM Comparison

Compare ENTA & BOOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTA
  • BOOM
  • Stock Information
  • Founded
  • ENTA 1995
  • BOOM 1965
  • Country
  • ENTA United States
  • BOOM United States
  • Employees
  • ENTA N/A
  • BOOM N/A
  • Industry
  • ENTA Biotechnology: Pharmaceutical Preparations
  • BOOM Industrial Specialties
  • Sector
  • ENTA Health Care
  • BOOM Industrials
  • Exchange
  • ENTA Nasdaq
  • BOOM Nasdaq
  • Market Cap
  • ENTA 164.6M
  • BOOM 166.0M
  • IPO Year
  • ENTA 2013
  • BOOM N/A
  • Fundamental
  • Price
  • ENTA $7.51
  • BOOM $8.05
  • Analyst Decision
  • ENTA Buy
  • BOOM Buy
  • Analyst Count
  • ENTA 5
  • BOOM 2
  • Target Price
  • ENTA $18.40
  • BOOM $16.25
  • AVG Volume (30 Days)
  • ENTA 173.3K
  • BOOM 125.2K
  • Earning Date
  • ENTA 08-08-2025
  • BOOM 08-05-2025
  • Dividend Yield
  • ENTA N/A
  • BOOM N/A
  • EPS Growth
  • ENTA N/A
  • BOOM N/A
  • EPS
  • ENTA N/A
  • BOOM N/A
  • Revenue
  • ENTA $64,462,999.00
  • BOOM $635,272,000.00
  • Revenue This Year
  • ENTA N/A
  • BOOM N/A
  • Revenue Next Year
  • ENTA $2.75
  • BOOM $4.32
  • P/E Ratio
  • ENTA N/A
  • BOOM N/A
  • Revenue Growth
  • ENTA N/A
  • BOOM N/A
  • 52 Week Low
  • ENTA $4.09
  • BOOM $6.02
  • 52 Week High
  • ENTA $15.92
  • BOOM $13.93
  • Technical
  • Relative Strength Index (RSI)
  • ENTA 51.19
  • BOOM 48.13
  • Support Level
  • ENTA $7.15
  • BOOM $8.00
  • Resistance Level
  • ENTA $8.31
  • BOOM $8.87
  • Average True Range (ATR)
  • ENTA 0.48
  • BOOM 0.47
  • MACD
  • ENTA 0.01
  • BOOM -0.04
  • Stochastic Oscillator
  • ENTA 55.73
  • BOOM 39.87

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

About BOOM DMC Global Inc.

DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.

Share on Social Networks: